Clinical Trials Directory

Trials / Unknown

UnknownNCT01021566

Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis

Advances in Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis: A Comparison Study With Conventional Methadone Treatment (HPDMT)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
First People's Hospital of Foshan · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether combined hemoperfusion-hemodialysis treatment is an alternative drug-free, effective, and safe treatment for opiate detoxification.

Detailed description

Drug abuse remains a major society problem in our community and is also a major health problem in our modern society. Thus, education to prevent the young generation to avoid drug abuse and detoxification to help those to quite from the drug abuse are two major key steps in the controlling drug abuse program. Currently, medications for opiate detoxification, such as methadone, are commonly used worldwide. However, methadone is also an addictive medication. When it is stopped suddenly, patients usually produce unpleasant withdrawal symptoms. Meanwhile, methadone is also potentially to be abused too. Thus, it is urgently needed to seek an alternative safer, effective, drug-free method for opiate detoxification. Based on our clinical observation, the timely clearance of toxicities from the body or blood is a safe and effective detoxification method. Thus, we hypothesized that the use of combined hemoperfusion-hemodialysis may be an alternative drug-free, effective, and safe treatment for opiate detoxification. This will be tested in patients who have severe drug abuse and are under custodial conditions by a daily combined hemoperfusion-hemodialysis for 3 days. The efficacy and safety of the hemoperfusion-hemodialysis will be compared to a 10 day standard methadone detoxification treatment.

Conditions

Interventions

TypeNameDescription
DEVICECombined hemoperfusion-hemodialysisCombined hemoperfusion-hemodialysis for opiate detoxification for 3 days
DRUGMethadoneOn admission all patients will undergo a 3-day stabilization period. Then they will begin the 10-day methadone treatment regimen. The starting dose of methadone is determined by the mean daily dose requirement during the stabilization period and the dose will be reduced to zero at a linear rate over the 10 days treatment.

Timeline

Start date
2009-11-01
Primary completion
2010-12-01
Completion
2011-06-01
First posted
2009-11-30
Last updated
2009-11-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01021566. Inclusion in this directory is not an endorsement.

Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis (NCT01021566) · Clinical Trials Directory